Corporate Documents

OKYO Pharma is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the main market for listed securities of the London Stock Exchange plc.

OKYO Pharma’s head office is located in Guernsey. Currently OKYO Pharma’s main country of operation and trading address is the United Kingdom.

OKYO Pharma is a Guernsey incorporated company and as such shareholders’ rights may be different from those of a company incorporated under the laws of England and Wales.

 

Results of AGM

6 September 2018
Click here to download (PDF 22 KB)

 

Notice of Annual General Meeting 2018

21 August 2018
Click here to download (PDF 260 KB)

 

Admission Prospectus to OKYO Pharma Ltd.

12 July 2018
Click here to download (PDF 1.9 MB)

 

Cancellation of AIM Listing and Migration Circular

21 February 2018
Click here to download (PDF 249 KB)

 

General Meeting Voting

10 January 2018
Click here to download (PDF 30 KB)

 

Memorandum of Association
Articles of Association

9 March 2018
Click here to download (PDF 1.58 MB)

 

Proposed Disposal and Special Dividend, Change of Name and Notice of General Meeting

21 December 2017

Click here to download (PDF 502 KB)